Correlation between Levels of Serum Lipoprotein-Associated Phospholipase A2 and Soluble Suppression of Tumorigenicity 2 and Condition of Acute Heart Failure Patients and Their Predictive Value for Prognosis

Figure 2

Comparison of serum LP-PLA2 and sST2 levels between the event group and the nonevent group (, ng/ml). (a) The LP-PLA2 and sST2 levels of patients in the severe group, and the comparison result was event group > nonevent group (321.68 ± 45.85 vs. 265.98 ± 35.68, 2,598.65 ± 52.98 vs. 1,968.65 ± 368.65, ). (b) The LP-PLA2 and sST2 levels of patients in the mild group, and the comparison result was event group > nonevent group (280.65 ± 35.65 vs. 172.65 ± 30.65, 2,125.65 ± 562.56 vs. 1,589.65 ± 350.58, ). (c) The LP-PLA2 and sST2 levels of 105 AHF patients, and the comparison result was event group > nonevent group (294.65 ± 35.65 vs. 190.68 ± 15.68, 2,435.65 ± 568.98 vs. 1,148.65 ± 420.68, ). Note. The horizontal axes indicated the event group and nonevent group; the black areas and gray areas, respectively, indicated LP-PLA2 and sST2; and # indicated .

(a)

(b)

(c)